These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38050716)

  • 1. A Proof-of-Concept Study on the Theranostic Potential of
    Chen X; Tan F; Liang R; Liao J; Yang J; Lan T; Yang Y; Liu N; Li F
    Chemistry; 2024 Feb; 30(9):e202303298. PubMed ID: 38050716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biocompatible conjugated polymer nanoparticles labeled with
    Chen X; Liang R; Liu W; Ma H; Bai C; Xiong Y; Lan T; Liao J; Yang Y; Yang J; Li F; Liu N
    Bioorg Med Chem; 2023 Dec; 96():117517. PubMed ID: 37939492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability and Biodistribution of Thiol-Functionalized and (177)Lu-Labeled Metal Chelating Polymers Bound to Gold Nanoparticles.
    Yook S; Lu Y; Jeong JJ; Cai Z; Tong L; Alwarda R; Pignol JP; Winnik MA; Reilly RM
    Biomacromolecules; 2016 Apr; 17(4):1292-302. PubMed ID: 26974228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro evaluation of
    Zhang J; Wang Z; Liu H; Cai L; Feng Y; Zhou L; Wei H; Xie Y; Chen Y
    Hell J Nucl Med; 2019; 22(2):103-110. PubMed ID: 31273351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts.
    Persson M; Rasmussen P; Madsen J; Ploug M; Kjaer A
    Nucl Med Biol; 2012 Oct; 39(7):962-9. PubMed ID: 22739362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumorally Injected 177Lu-Labeled Gold Nanoparticles: Gold Nanoseed Brachytherapy with Application for Neoadjuvant Treatment of Locally Advanced Breast Cancer.
    Yook S; Cai Z; Lu Y; Winnik MA; Pignol JP; Reilly RM
    J Nucl Med; 2016 Jun; 57(6):936-42. PubMed ID: 26848176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Panitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to
    Aghevlian S; Lu Y; Winnik MA; Hedley DW; Reilly RM
    Mol Pharm; 2018 Mar; 15(3):1150-1159. PubMed ID: 29314858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiolabeling of a polypeptide polymer for intratumoral delivery of alpha-particle emitter,
    Shalgunov V; Engudar G; Bohrmann L; Wharton L; Maskell K; Johann K; Barz M; Schaffer P; Herth MM; Radchenko V
    Nucl Med Biol; 2022; 104-105():11-21. PubMed ID: 34839209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted antisense radiotherapy and dose fractionation using a (177)Lu-labeled anti-bcl-2 peptide nucleic acid-peptide conjugate.
    Liu D; Balkin ER; Jia F; Ruthengael VC; Smith CJ; Lewis MR
    Nucl Med Biol; 2015 Sep; 42(9):704-10. PubMed ID: 26081917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted systemic radiotherapy with scVEGF/177Lu leads to sustained disruption of the tumor vasculature and intratumoral apoptosis.
    Blankenberg FG; Levashova Z; Goris MG; Hamby CV; Backer MV; Backer JM
    J Nucl Med; 2011 Oct; 52(10):1630-7. PubMed ID: 21890879
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Pirooznia N; Abdi K; Beiki D; Emami F; Arab SS; Sabzevari O; Soltani-Gooshkhaneh S
    Bioorg Chem; 2020 Sep; 102():104100. PubMed ID: 32711088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical Characterization of DPI-4452: A
    Massière F; Wiedemann N; Borrego I; Hoehne A; Osterkamp F; Paschke M; Zboralski D; Schumann A; Bredenbeck A; Brichory F; Attinger A
    J Nucl Med; 2024 May; 65(5):761-767. PubMed ID: 38514083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The preclinical study of
    Molavipordanjani S; Mousavi T; Khorramimoghaddam A; Talebpour Amiri F; Abedi SM; Hosseinimehr SJ
    Ann Nucl Med; 2023 Jul; 37(7):400-409. PubMed ID: 37115407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A radio-theranostic nanoparticle with high specific drug loading for cancer therapy and imaging.
    Satterlee AB; Yuan H; Huang L
    J Control Release; 2015 Nov; 217():170-82. PubMed ID: 26341695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of Lys¹(α,γ-Folate)Lys³(¹⁷⁷Lu-DOTA)-Bombesin(1-14) as a potential theranostic radiopharmaceutical for breast cancer.
    Aranda-Lara L; Ferro-Flores G; Azorín-Vega E; Ramírez FM; Jiménez-Mancilla N; Ocampo-García B; Santos-Cuevas C; Isaac-Olivé K
    Appl Radiat Isot; 2016 Jan; 107():214-219. PubMed ID: 26545016
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Huang Y; Yang Z; Li F; Zhao H; Li C; Yu N; Hamilton DJ; Li Z
    J Med Chem; 2021 Mar; 64(5):2705-2713. PubMed ID: 33646782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results.
    Nock BA; Kaloudi A; Lymperis E; Giarika A; Kulkarni HR; Klette I; Singh A; Krenning EP; de Jong M; Maina T; Baum RP
    J Nucl Med; 2017 Jan; 58(1):75-80. PubMed ID: 27493272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary evaluation of (177)Lu-labeled knottin peptides for integrin receptor-targeted radionuclide therapy.
    Jiang L; Miao Z; Kimura RH; Liu H; Cochran JR; Culter CS; Bao A; Li P; Cheng Z
    Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):613-22. PubMed ID: 21153409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological inhibition of mTORC1 increases CCKBR-specific tumor uptake of radiolabeled minigastrin analogue [
    Grzmil M; Qin Y; Schleuniger C; Frank S; Imobersteg S; Blanc A; Spillmann M; Berger P; Schibli R; Behe M
    Theranostics; 2020; 10(24):10861-10873. PubMed ID: 33042258
    [No Abstract]   [Full Text] [Related]  

  • 20. Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide Therapy.
    Garcia-Prada CD; Carmes L; Atis S; Parach A; Bertolet A; Jarlier M; Poty S; Garcia DS; Shin WG; Du Manoir S; Schuemann J; Tillement O; Lux F; Constanzo J; Pouget JP
    J Nucl Med; 2023 Dec; 64(12):1956-1964. PubMed ID: 37857502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.